Abivax

Abivax's latest funding round allows the biotech to move toward a U.S. launch of its bowel disease drug without…
Read More...

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel…
Read More...

Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug for…
Read More...